Miscellaneous Flashcards

HLH, PNH, Gene therapy, novel approaches to Hb-opathies

1
Q

Inherited causes of HLH (Haemophagocytic lymphohistiocytosis)?

A
  • Familial (FHL)

- Immune deficiency syndromes (Eg Griscelli syndrome II)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

-Acquired causes of HLH (Haemophagocytic lymphohistiocytosis)?

A
  • Infections (eg leishmanial)
    - Tumours (eg EBV associated lymphomas)
    - Autoimmune disorders (eg SLE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical manifestations of HLH (Haemophagocytic lymphohistiocytosis)?

A
  • Organ infiltration by T cells causing
    - Haemophagocytosis (Macrophages engulfing red cells)
    - Cytokine storm (By T cells and macrophages)
  • These effects result in: Fever, hepatosplenomegaly, lymphadenopathy, bone marrow failure (And many more)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

-Pathogenesis of HLH (Haemophagocytic lymphohistiocytosis)?

A

Perforin is an essential protein in inducing apoptosis by CTLS or NKs

  • Perforin failure
  • CTLs cannot execute apoptosis, causing upregulation
  • Homeostasis of cytotoxic lymphocyte responses becomes deregulated
    - Clonal and polyclonal expansion of CTLs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the pathophysiology of paroxysmal nocturnal haemoglobinuria (PNH)

A
  • Deficiency in the glycosylphosphatidylinositol (GPI) anchor found on marrow stem cells
  • This deficiency leads to a deficiency of GPI-linked proteins (Such as the membrane inhibitor of reactive lysis (MIRL) aka CD59)
  • Red cells that descend from these stem cells also lack GPI and GPI-linked proteins, so become sensitive to lysis by complement. (especially MIRL/CD59, DAF/CD55)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical features of paroxysmal nocturnal haemoglobinuria (PNH)?

A
  • Chronic intravascular haemolysis
  • Anaemia
    - Nitric oxide depletion
    - Thrombosis at unusual anatomical sites
    - Bone marrow failure (BMF) and cytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

-Treatment of PNH-anaemia?

A
  • Iron and folate supplements
    - Blood transfusion
    - Inhibition of haemolysis (Steroids or Complement inhibitors)
    - Eculizumab: mAb: C5 inhibitor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

-Describe how gene therapy is being used in the treatment of SCD

A
  • A psuedotyped lentivirus is used to inject wild-type Beta globin genes into HSCs, along with control sequences such as LCRs
  • Lentiglobin BB305 has shown promising results
    - Vector derived haemoglobin production improves clinical picture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give an example of a novel approach for the treatment of sickle cell

A

Prevention of vaso-occlusion by P-selectin inhibitor Crizanlizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the main psychosocial problems in children with Sickle Cell Disease?

A
  • Emotional challenge: Coming to terms with the illness
  • Cognitive impairment leads to educational problems, where extra support may be required
  • Adherence to treatment is also a problem
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain the treatment of PNH

A
  • Iron and folate supplements, Blood transfusion: to correct anaemia
  • Eculizumab: mAb: C5 inhibitor.
  • This mAb blocks the terminal complement pathway
  • Membrane attack complex is not formed as a result
  • This stops haemolysis mediated by complement
  • Steroids can also be used to inhibit haemolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is PNH diagnosed?

A

clinical features:

- Chronic intravascular haemolysis - Anaemia
			- Nitric oxide depletion
		- Thrombosis at unusual anatomical sites
		- Bone marrow failure (BMF) and cytopenia

-Diagnosis confirmed with flow cytometry: presence of CD55 and CD59

How well did you know this?
1
Not at all
2
3
4
5
Perfectly